Abstract
Objective: The aim of the present study was to determine specific obstetrical and neonatal complications associated with diet-treated gestational diabetes (DTGD) and medically treated gestational diabetes (MTGD).
Methods: This is a prospective cohort study of women followed in the Robert Debré Hospital (France, Paris) and who have given birth between 1 January, 2004, and 19 November, 2010. Clinical, biological, maternal and neonatal data were reported in the maternity database. Associations between obstetrical and neonatal complications and gestational diabetes were evaluated by estimating odd ratios (ORs) and their 95% CIs, using a logistic regression model.
Results: 16,244 pregnancies were included in the study. 1515 (9.3%) women had gestational diabetes: 1108 (7.3%) had DTGD, 243 (1.7%) had MTGD. After full adjustment, MTGD was associated with an increased risk of nonscheduled cesarean (ORnonscheduled=2.3; 95% CI: 1.6–3.3; P<0.001) while DTGD was not (ORnonscheduled=1.0; 95% CI: 0.8–1.3; P<0.96). Clinical macrosomia was positively associated with DTGD (OR=2; 95% CI: 1.7–2.4; P<0.0001) or MTGD (OR=2.9; 95% CI: 2.1–3.9; P<0.0001).
Conclusion: This study confirms that macrosomia is the main complication of DTGD. By contrast, DTGD was not associated with neonatal hypoglycemia and cesarean, while these complications were associated with MTGD.
References
[1] Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115:445–52.10.1111/j.1471-0528.2007.01644.xSearch in Google Scholar
[2] Casey BM, Lucas MJ, Mcintire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol. 1997;90:869–73.10.1016/S0029-7844(97)00542-5Search in Google Scholar
[3] Cheng YW, McLaughlin GB, Esakoff TF, Block-Kurbisch I, Caughey AB. Glucose challenge test: screening threshold for gestational diabetes mellitus and associated outcomes. J Matern Fetal Neonatal Med. 2007;20:903–8.10.1080/14767050701739384Search in Google Scholar PubMed
[4] Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005;28:579–84.10.2337/diacare.28.3.579Search in Google Scholar PubMed
[5] Durnwald CP, Mele L, Spong CY, Ramin SM, Varner MW, Rouse DJ, et al. Glycemic characteristics and neonatal outcomes of women treated for mild gestational diabetes. Obstet Gynecol. 2011;117:819–27.10.1097/AOG.0b013e31820fc6cfSearch in Google Scholar PubMed PubMed Central
[6] Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30 (Suppl 2):S141–146.10.2337/dc07-s206Search in Google Scholar PubMed
[7] Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP Jr., Selby JV, Ergas IJ, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds. but below the National Diabetes Data Group thresholds for gestational diabetes mellitus. Are related to the risk of neonatal macrosomia. hypoglycaemia and hyperbilirubinaemia. Diabetologia. 2007;50:298–306.10.1007/s00125-006-0517-8Search in Google Scholar PubMed
[8] Hiéronimus S, Le Meaux J-P. Relevance of gestational diabetes mellitus screening and comparison of selective with universal strategies. Diabetes Metab. 2010;36(6 Pt 2):575–86.10.1016/j.diabet.2010.11.010Search in Google Scholar PubMed
[9] Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand. 2008;87:59–62.10.1080/00016340701823975Search in Google Scholar PubMed
[10] Ju H, Rumbold AR, Willson KJ, Crowther CA. Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy Childbirth. 2008;8:31.10.1186/1471-2393-8-31Search in Google Scholar PubMed PubMed Central
[11] Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter. randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.10.1056/NEJMoa0902430Search in Google Scholar PubMed PubMed Central
[12] Luoto R, Kinnunen TI, Aittasalo M, Kolu P, Raitanen J, Ojala K, et al. Primary prevention of gestational diabetes mellitus and large-for-gestational-age newborns by lifestyle counseling: a cluster-randomized controlled trial. PLoS Med. 2011;8:e1001036.10.1371/journal.pmed.1001036Search in Google Scholar PubMed PubMed Central
[13] Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.10.1056/NEJMoa0707943Search in Google Scholar PubMed
[14] Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Pediatrics. 1994;94(4 Pt 1):558–65.10.1542/peds.94.4.558Search in Google Scholar
[15] Stotland NE, Caughey AB, Breed EM, Escobar GJ. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet. 2004;87:220–6.10.1016/j.ijgo.2004.08.010Search in Google Scholar PubMed
[16] Tieu J, Crowther CA, Middleton P. Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2008:CD006674.10.1002/14651858.CD006674.pub2Search in Google Scholar PubMed
[17] Vendittelli F, Rivière O, Crenn-Hébert C, Claris O, Tessier V, Pinquier D, et al. [Audipog perinatal network. Part 1: principal perinatal health indicators. 2004–2005]. Gynecol Obstet Fertil. 2008;36:1091–100.10.1016/j.gyobfe.2008.08.010Search in Google Scholar PubMed
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2014 by Walter de Gruyter Berlin Boston
